Related Experiment Video
Updated: Aug 24, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor
Leilani L Santos1, Derek Lacey, Yuanhang Yang
1Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton, Melbourne, Australia. lanie.santos@med.monash.edu.au
Objective:
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine important in animal models of rheumatoid arthritis (RA). We investigated the utilization by MIF of mitogen activated protein (MAP) kinase signalling pathways in the stimulation of fibroblast-like synoviocytes (FLS), cyclooxygenase-2 (COX-2), prostaglandin E(2) (PGE(2)), and interleukin 6 (IL-6) and IL-8 expression.
Methods:
Cultured human RA FLS were treated with recombinant MIF. Activation of MAPK was measured by Western blotting and blocked using specific inhibitors. The expression of COX-2, PGE(2), IL-6, and IL-8 were measured using flow cytometry, ELISA, and real-time polymerase chain reaction.
Results:
MIF induced the phosphorylation of FLS p38 and extracellular-signal regulated kinase (ERK) MAP kinase. MIF significantly induced COX-2 and IL-6 protein and mRNA expression as well as PGE(2) and IL-8 production. Antagonism of p38 MAP kinase inhibited MIF induction of COX-2, PGE(2), and IL-6. In contrast, antagonism of ERK had no effect on COX-2, PGE(2), or IL-6. Neither antagonist inhibited MIF-induced IL-8.
Conclusion:
MIF activates RA FLS COX-2 and IL-6 expression via p38 MAP kinase activation and induces IL-8 via p38 and ERK MAP kinase-independent pathways.
Insights
Macrophage migration inhibitory factor (MIF) activates rheumatoid arthritis fibroblast-like synoviocytes via p38 MAP kinase, increasing COX-2 and IL-6. IL-8 production is independent of these pathways.
Area of Science:
- Immunology
- Molecular Biology
- Rheumatology
Background:
- Macrophage migration inhibitory factor (MIF) is a key proinflammatory cytokine in rheumatoid arthritis (RA) pathogenesis.
- Fibroblast-like synoviocytes (FLS) play a critical role in RA joint inflammation.
Purpose of the Study:
- To investigate the role of mitogen-activated protein (MAP) kinase pathways in MIF-induced FLS activation.
- To determine the involvement of MAP kinases in the expression of cyclooxygenase-2 (COX-2), prostaglandin E(2) (PGE(2)), IL-6, and IL-8.
Main Methods:
- Human RA FLS were stimulated with recombinant MIF.
- MAP kinase activation (p38 and ERK) was assessed via Western blotting and specific inhibitors.
- COX-2, PGE(2), IL-6, and IL-8 levels were quantified using flow cytometry, ELISA, and real-time PCR.
Main Results:
- MIF induced p38 and ERK phosphorylation in FLS.
- MIF significantly upregulated COX-2, IL-6, PGE(2), and IL-8.
- Inhibition of p38 MAP kinase blocked MIF-induced COX-2, PGE(2), and IL-6.
- ERK inhibition did not affect COX-2, PGE(2), or IL-6; neither inhibitor affected IL-8 induction.
Conclusions:
- MIF activates COX-2 and IL-6 expression in RA FLS through p38 MAP kinase activation.
- MIF induces IL-8 production via pathways independent of both p38 and ERK MAP kinases.
Related Concept Videos
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...